Literature DB >> 31597703

Ostreolysin A and anthrolysin O use different mechanisms to control movement of cholesterol from the plasma membrane to the endoplasmic reticulum.

Kristen A Johnson1, Shreya Endapally1, Danya C Vazquez1, Rodney E Infante2,3,4,5, Arun Radhakrishnan6.   

Abstract

Recent studies using two cholesterol-binding bacterial toxin proteins, perfringolysin O (PFO) and domain 4 of anthrolysin O (ALOD4), have shown that cholesterol in the plasma membranes (PMs) of animal cells resides in three distinct pools. The first pool comprises mobile cholesterol, accessible to both PFO and ALOD4, that is rapidly transported to the endoplasmic reticulum (ER) to signal cholesterol excess and maintain cholesterol homeostasis. The second is a sphingomyelin (SM)-sequestered pool inaccessible to PFO and ALOD4 but that becomes accessible by treatment with SM-degrading sphingomyelinase (SMase). The third is an essential pool also inaccessible to PFO and ALOD4 that cannot be liberated by SMase treatment. The accessible cholesterol pool can be trapped on PMs of live cells by nonlytic ALOD4, blocking its transport to the ER. However, studies of the two other pools have been hampered by a lack of available tools. Here, we used ostreolysin A (OlyA), which specifically binds SM/cholesterol complexes in membranes, to study the SM-sequestered cholesterol pool. Binding of nonlytic OlyA to SM/cholesterol complexes in PMs of live cells depleted the accessible PM cholesterol pool detectable by ALOD4. Consequently, transport of accessible cholesterol from PM to ER ceased, thereby activating SREBP transcription factors and increasing cholesterol synthesis. Thus, OlyA and ALOD4 both control movement of PM cholesterol, but through different lipid-binding mechanisms. We also found that PM-bound OlyA was rapidly internalized into cells, whereas PM-bound ALOD4 remained on the cell surface. Our findings establish OlyA and ALOD4 as complementary tools to investigate cellular cholesterol transport.
© 2019 Johnson et al.

Entities:  

Keywords:  cellular pool; cholesterol regulation; domain 4 of anthrolysin O (ALOD4); endoplasmic reticulum (ER); lipid transport; membrane organization; ostreolysin A (OlyA); plasma membrane; sphingolipid; sterol regulatory element-binding protein (SREBP)

Mesh:

Substances:

Year:  2019        PMID: 31597703      PMCID: PMC6873175          DOI: 10.1074/jbc.RA119.010393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma.

Authors:  Jeffrey G McDonald; Daniel D Smith; Ashlee R Stiles; David W Russell
Journal:  J Lipid Res       Date:  2012-04-19       Impact factor: 5.922

2.  Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution.

Authors:  B W Wattenberg; D F Silbert
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

3.  Switch-like responses of two cholesterol sensors do not require protein oligomerization in membranes.

Authors:  Austin Gay; Daphne Rye; Arun Radhakrishnan
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

4.  Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding.

Authors:  John J Flanagan; Rodney K Tweten; Arthur E Johnson; Alejandro P Heuck
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

5.  How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids.

Authors:  Yvonne Lange; Jin Ye; Theodore L Steck
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

6.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe.

Authors:  L Liscum; K L Luskey; D J Chin; Y K Ho; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

7.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

8.  Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig.

Authors:  Arun Radhakrishnan; Yukio Ikeda; Hyock Joo Kwon; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

9.  Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis.

Authors:  Akash Das; Michael S Brown; Donald D Anderson; Joseph L Goldstein; Arun Radhakrishnan
Journal:  Elife       Date:  2014-06-11       Impact factor: 8.140

10.  Continuous transport of a small fraction of plasma membrane cholesterol to endoplasmic reticulum regulates total cellular cholesterol.

Authors:  Rodney Elwood Infante; Arun Radhakrishnan
Journal:  Elife       Date:  2017-04-17       Impact factor: 8.140

View more
  13 in total

1.  Accessibility of cholesterol at cell surfaces.

Authors:  Kristen A Johnson; Arun Radhakrishnan
Journal:  J Lipid Res       Date:  2020-04-23       Impact factor: 5.922

2.  Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex.

Authors:  Tomoki Naito; Bilge Ercan; Logesvaran Krshnan; Alexander Triebl; Dylan Hong Zheng Koh; Fan-Yan Wei; Kazuhito Tomizawa; Federico Tesio Torta; Markus R Wenk; Yasunori Saheki
Journal:  Elife       Date:  2019-11-14       Impact factor: 8.140

3.  Molecular basis of accessible plasma membrane cholesterol recognition by the GRAM domain of GRAMD1b.

Authors:  Bilge Ercan; Tomoki Naito; Dylan Hong Zheng Koh; Dennis Dharmawan; Yasunori Saheki
Journal:  EMBO J       Date:  2021-02-19       Impact factor: 11.598

4.  Sphingolipids and Cholesterol.

Authors:  Xian-Cheng Jiang; Zhiqiang Li
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Sphingosine kinases regulate ER contacts with late endocytic organelles and cholesterol trafficking.

Authors:  Elisa N D Palladino; Tytus Bernas; Christopher D Green; Cynthia Weigel; Sandeep K Singh; Can E Senkal; Andrea Martello; John P Kennelly; Erhard Bieberich; Peter Tontonoz; David A Ford; Sheldon Milstien; Emily R Eden; Sarah Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-19       Impact factor: 12.779

6.  Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol.

Authors:  Michael E Abrams; Kristen A Johnson; Sofya S Perelman; Li-Shu Zhang; Shreya Endapally; Katrina B Mar; Bonne M Thompson; Jeffrey G McDonald; John W Schoggins; Arun Radhakrishnan; Neal M Alto
Journal:  Nat Microbiol       Date:  2020-04-13       Impact factor: 17.745

7.  The use of anthrolysin O and ostreolysin A to study cholesterol in cell membranes.

Authors:  Kristen A Johnson; Arun Radhakrishnan
Journal:  Methods Enzymol       Date:  2021-02-16       Impact factor: 1.600

8.  Measuring and Manipulating Membrane Cholesterol for the Study of Hedgehog Signaling.

Authors:  Maia Kinnebrew; Kristen A Johnson; Arun Radhakrishnan; Rajat Rohatgi
Journal:  Methods Mol Biol       Date:  2022

9.  Cholesterol accessibility at the ciliary membrane controls hedgehog signaling.

Authors:  Maia Kinnebrew; Ellen J Iverson; Bhaven B Patel; Ganesh V Pusapati; Jennifer H Kong; Kristen A Johnson; Giovanni Luchetti; Kaitlyn M Eckert; Jeffrey G McDonald; Douglas F Covey; Christian Siebold; Arun Radhakrishnan; Rajat Rohatgi
Journal:  Elife       Date:  2019-10-30       Impact factor: 8.140

Review 10.  STARD1 Functions in Mitochondrial Cholesterol Metabolism and Nascent HDL Formation. Gene Expression and Molecular mRNA Imaging Show Novel Splicing and a 1:1 Mitochondrial Association.

Authors:  Michele Campaigne Larsen; Jinwoo Lee; Joan S Jorgensen; Colin R Jefcoate
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.